Publication | Closed Access
Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12.
29
Citations
0
References
2004
Year
Adjuvant EffectImmunologyImmunotherapyTumor ImmunityE7 ProteinVaccine DevelopmentTherapeutic VaccineVirologyRecombinant Vaccinia VirusCell BiologyDendritic CellsVaccinationCancer ImmunosurveillanceLow MultiplicityAntiviral ResponseDendritic Cell BiologyVaccine DesignMedicineViral Immunity
Dendritic cells (DC) enhanced the immunogenicity of recombinant vaccinia viruses (rVV) expressing the E7 protein of HPV16, a tumor-associated antigen (TAA). Immunization with DC transduced by rVV generated from strain Praha or MVA induced better protection against the growth of transplanted TC-1 tumors in C57Bl/6 mice than did immunization with either of these rVVs administered alone by the same route. Interestingly, DC transduced with a double recombinant vaccinia virus expressing E7 protein together with the Th1-polarizing cytokine IL12, which has been shown to enhance the cellular response in several other systems, induced lower anti-tumor immunity than DC transduced with rVV expressing E7 protein alone. The inhibitory effect mediated by IL12 on immunization with rVV-infected DC was dose-dependent and was observed after immunization with DC transduced with IL12-expressing rVV even at low multiplicity.